HALO logo
halo search icon
4502
Takeda Pharmaceutical Co. Ltd.

4502 · Takeda Pharmaceutical Co. Ltd.

5816.00

JPY
50.00 (0.867%)
08/10/2026 12:00:00 AM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

JPY9.24T

PE

36.60

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

164%

MQV Rating

3Neutral

As at 08/10/2026 12:00:00 AM

Price Chart

Description

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following business divisions: Gastrointestinal Diseases, Rare Diseases, Plasma-Derived Therapies, Oncology, Vaccines, and Neuroscience The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

  • All-Companies
  • All-Consensus
  • ALL-Recommendations
  • HALO 200
  • HALO 500
  • HALO All
  • HALO Growth

Key Fundamentals

EPS 3 yr Growth

32.20%

EBITDA Margin

42.10%

Operating Cashflow

¥1,041,431m

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

5.30

Quick Ratio

N/A

Performance

52 weeks range

Low 4102 - 6033

Trade Value (12mth)

US$35,619,081.00

1 week

-0.24%

1 month

0.23%

YTD

17.29%

1 year

29.84%

All time high

8430.00

Additional Data

Shares Outstanding (Fully Diluted)

1,605m

HALO Sector

Healthcare

Next Company Report Date

13-May-27

Next Ex Dividend Date

30-Mar-27

Next Dividend Pay Date

30-Mar-27

Reporting Currency

JPY

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Neutral

Garp

Strong

Mqv Small

Neutral

Momentum

Price

Neutral

Earnings

Neutral

Growth

Earnings

Very Strong

Dividends

Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
Takeda Pharmaceutical Co., Ltd.Public Company
Takeda Pharmaceutical Employee Incentive PlanTrust/Trustee
Takeda Pharmaceutical Director Incentive PlanTrust/Trustee
Christophe P. WeberIndividual
Medipal Holdings Corp.Public Company

See beyond the curve.

One solution for research, investing and model portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Takeda Pharmaceutical Co. Ltd. (4502:TKS)?
Halo FAQ
The current share price of Takeda Pharmaceutical Co. Ltd. (4502:TKS) is JPY¥5816.00.
2
What is the 52-week high share price for Takeda Pharmaceutical Co. Ltd. (4502:TKS)?
Halo FAQ
The 52-week high share price for Takeda Pharmaceutical Co. Ltd. (4502:TKS) is JPY¥6033.00.
3
What is the 52-week low share price for Takeda Pharmaceutical Co. Ltd. (4502:TKS)?
Halo FAQ
The 52-week low share price for Takeda Pharmaceutical Co. Ltd. (4502:TKS) is JPY¥4102.00.
4
What is the dividend yield for Takeda Pharmaceutical Co. Ltd. (4502:TKS)?
Halo FAQ
Takeda Pharmaceutical Co. Ltd. (4502:TKS) does not pay a dividend.
5
What was Takeda Pharmaceutical Co. Ltd. (4502:TKS) last dividend payment?
Halo FAQ
The last dividend payment of Takeda Pharmaceutical Co. Ltd. (4502:TKS) is JPY¥1.02.
6
What is the franking level for Takeda Pharmaceutical Co. Ltd. (4502:TKS)?
Halo FAQ
Takeda Pharmaceutical Co. Ltd. (4502:TKS) has a franking level of 0.00%.
7
In which sector is Takeda Pharmaceutical Co. Ltd. (4502:TKS) classified?
Halo FAQ
Takeda Pharmaceutical Co. Ltd. (4502:TKS) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Takeda Pharmaceutical Co. Ltd. (4502:TKS)?
Halo FAQ
The current P/E ratio for Takeda Pharmaceutical Co. Ltd. (4502:TKS) is 36.60.